|
Titan Biotech Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
364.43 Cr.
|
P/BV
|
2.65
|
Book Value (Rs.)
|
166.49
|
|
52 Week High/Low (Rs.)
|
1018/407
|
FV/ML
|
10/1
|
P/E(X)
|
14.66
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
30.07
|
Div Yield (%)
|
0.45
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 30.07 | 25.44 | 30.66 | 36.71 | 8.55 |
| Diluted EPS (Rs.) | 30.07 | 25.44 | 30.66 | 36.71 | 8.55 |
| Cash EPS (Rs.) | 32.66 | 28.59 | 37.62 | 41.05 | 11.66 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 161.49 | 133.00 | 127.56 | 87.70 | 50.27 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 161.49 | 133.00 | 127.56 | 87.70 | 50.27 |
| Revenue From Operations / Share (Rs.) | 198.54 | 174.26 | 184.92 | 172.12 | 96.13 |
| PBDIT / Share (Rs.) | 43.60 | 38.07 | 50.85 | 56.77 | 16.85 |
| PBIT / Share (Rs.) | 39.57 | 34.93 | 47.78 | 54.09 | 14.67 |
| PBT / Share (Rs.) | 38.15 | 34.02 | 46.22 | 51.68 | 12.59 |
| Net Profit / Share (Rs.) | 28.64 | 25.44 | 34.55 | 38.37 | 9.48 |
| NP After MI And SOA / Share (Rs.) | 30.07 | 30.06 | 34.78 | 36.71 | 8.55 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 21.95 | 21.84 | 27.49 | 32.98 | 17.53 |
| PBIT Margin (%) | 19.92 | 20.04 | 25.83 | 31.42 | 15.26 |
| PBT Margin (%) | 19.21 | 19.52 | 24.99 | 30.02 | 13.09 |
| Net Profit Margin (%) | 14.42 | 14.60 | 18.68 | 22.29 | 9.86 |
| NP After MI And SOA Margin (%) | 15.14 | 17.25 | 18.80 | 21.32 | 8.89 |
| Return on Networth / Equity (%) | 18.62 | 22.60 | 29.13 | 44.11 | 18.02 |
| Return on Capital Employeed (%) | 23.78 | 25.28 | 33.41 | 54.77 | 21.80 |
| Return On Assets (%) | 15.87 | 18.46 | 20.04 | 30.11 | 9.29 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.08 | 0.07 | 0.29 |
| Total Debt / Equity (X) | 0.05 | 0.06 | 0.16 | 0.19 | 0.58 |
| Asset Turnover Ratio (%) | 1.13 | 1.04 | 1.19 | 1.51 | 1.07 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 3.77 | 3.36 | 3.62 | 3.10 | 2.16 |
| Quick Ratio (X) | 1.39 | 1.58 | 1.94 | 1.40 | 0.79 |
| Inventory Turnover Ratio (X) | 1.98 | 1.80 | 1.76 | 2.03 | 1.62 |
| Dividend Payout Ratio (NP) (%) | 5.98 | 4.98 | 4.31 | 2.72 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 5.27 | 4.51 | 3.96 | 2.53 | 0.00 |
| Earning Retention Ratio (%) | 94.02 | 95.02 | 95.69 | 97.28 | 0.00 |
| Cash Earning Retention Ratio (%) | 94.73 | 95.49 | 96.04 | 97.47 | 0.00 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 30.79 | 42.18 | 32.76 | 28.13 | 5.96 |
| Interest Coverage Ratio (Post Tax) (%) | 21.22 | 29.19 | 23.26 | 20.21 | 4.09 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 440.82 | 164.81 | 223.56 | 164.56 | 58.63 |
| EV / Net Operating Revenue (X) | 2.69 | 1.14 | 1.46 | 1.16 | 0.73 |
| EV / EBITDA (X) | 12.23 | 5.24 | 5.32 | 3.51 | 4.21 |
| MarketCap / Net Operating Revenue (X) | 2.66 | 1.13 | 1.42 | 1.08 | 0.44 |
| Retention Ratios (%) | 94.01 | 95.01 | 95.68 | 97.27 | 0.00 |
| Price / BV (X) | 3.27 | 1.48 | 2.19 | 2.23 | 0.89 |
| Price / Net Operating Revenue (X) | 2.66 | 1.13 | 1.42 | 1.08 | 0.44 |
| EarningsYield | 0.05 | 0.15 | 0.13 | 0.19 | 0.20 |
